v3.19.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue
Operating expenses:    
Research and development 445,402 692,725
Sales and marketing 57,016 12,500
Depreciation and amortization 29,703 30,561
General and administrative 1,854,684 449,029
Total operating expenses 2,386,805 1,184,815
Loss from operations (2,386,805) (1,184,815)
Other (expense) income:    
Interest expense (822,858) (166,887)
Interest income 1,318 37
Total other (expense) income (821,540) (166,850)
Loss before income taxes (3,208,345) (1,351,665)
Income tax (expense) benefit
Net loss (3,208,345) (1,351,665)
Dividend to series A and B preferred stockholders (160,219) (320,000)
Net loss attributable to common stockholders $ (3,368,564) $ (1,671,665)
Net loss per common share, basic and diluted (in dollars per share) $ (0.43) $ (0.92)
Weighted average number of common shares outstanding, basic and diluted (in shares) 7,745,378 1,820,556

Source